Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Unknown 2Recruiting 2Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 7Breast 6Gastrointestinal 2Dermatologic 2

Conditions

Melanoma 2Neoplasm Micrometastasis 1Lymphatic Metastasis 1

Interventions

Nivolumab 27pembrolizumab 22Ipilimumab 17Temozolomide 13toripalimab 12Biopsy 10Cyclophosphamide 9Imiquimod 8Dacarbazine 7Blood Specimen Collection 7camrelizumab 6Chemotherapy, Adjuvant 6trametinib 5fludarabine 5dabrafenib 5atezolizumab 5aldesleukin 5Gene Expression Profiling 5Cisplatin 5Aminolevulinic Acid 5fludarabine phosphate 4durvalumab 4binimetinib 4apatinib 4Tomography, Optical Coherence 4Sorafenib 4Photochemotherapy 4Interleukin-2 4Injections 4Carboplatin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Sentinel Lymph Node Biopsy × Dermatologic × Clear all
NCT02142244 2017-02-02

Fluorescence Surgery for Sentinel Node Identification in Melanoma

Barretos Cancer Hospital

Phase NA Unknown
318 enrolled
Dermatologic

Lymphatic Metastasis, Melanoma, Neoplasm Micrometastasis

NCT00897481 2013-08-12

Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy

National Cancer Institute (NCI)

Unknown
1,000 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡